{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:41Z","timestamp":1786985441724,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.bone.2013.08.013","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T16:06:12Z","timestamp":1377187572000},"page":"269-271","source":"Crossref","is-referenced-by-count":35,"title":["Proton pump inhibitor use and fracture risk \u2014 effect modification by histamine H1 receptor blockade. Observational case\u2013control study using National Prescription Data"],"prefix":"10.1016","volume":"57","author":[{"given":"Bo","family":"Abrahamsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bone.2013.08.013_bb0005","first-page":"e228","article-title":"Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting","volume":"16","author":"Heidelbaugh","year":"2010","journal-title":"Am J Manag Care"},{"issue":"6","key":"10.1016\/j.bone.2013.08.013_bb0010","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/MOG.0b013e32833ea9d9","article-title":"Adverse effects of proton pump inhibitor drugs: clues and conclusions","volume":"26","author":"McCarthy","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"10.1016\/j.bone.2013.08.013_bb0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2036.2012.05201.x","article-title":"Systematic review: hypomagnesaemia induced by proton pump inhibition","volume":"36","author":"Hess","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.bone.2013.08.013_bb0020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjmed.2011.01.007","article-title":"Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies","volume":"124","author":"Yu","year":"2011","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.bone.2013.08.013_bb0025","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-012-2112-9","article-title":"The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study","volume":"24","author":"Fraser","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.08.013_bb0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00223-006-0021-7","article-title":"Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture","volume":"79","author":"Vestergaard","year":"2006","journal-title":"Calcif Tissue Int"},{"issue":"April 2011","key":"10.1016\/j.bone.2013.08.013_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jcb.23337","volume":"147","author":"Fossmark","year":"2012","journal-title":"Cell Biochem"},{"issue":"2","key":"10.1016\/j.bone.2013.08.013_bb0040","first-page":"439","article-title":"Do proton pump inhibitors decrease calcium absorption?","volume":"26","author":"Hansen","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.bone.2013.08.013_bb0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.00015.2012","article-title":"Gastric acid, calcium absorption, and their impact on bone health","volume":"93","author":"Kopic","year":"2013","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1016\/j.bone.2013.08.013_bb0050","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11894-012-0290-4","article-title":"Chronic proton pump inhibitor therapy and calcium metabolism","volume":"14","author":"Yang","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"issue":"2","key":"10.1016\/j.bone.2013.08.013_bb0055","first-page":"117","article-title":"Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus","volume":"30","author":"Nishi","year":"2005","journal-title":"Tokai J Exp Clin Med"},{"issue":"1","key":"10.1016\/j.bone.2013.08.013_bb0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1210\/jcem-72-1-140","article-title":"Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study","volume":"72","author":"Chines","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bone.2013.08.013_bb0065","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2353\/ajpath.2009.080871","article-title":"Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts","volume":"174","author":"Biosse-Duplan","year":"2009","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.bone.2013.08.013_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwf007","article-title":"Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark","volume":"156","author":"Vestergaard","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.bone.2013.08.013_bb0075","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/oxfordjournals.aje.a116396","article-title":"Selection of controls in case\u2013control studies. I. Principles","volume":"135","author":"Wacholder","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.bone.2013.08.013_bb0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3233\/JRS-1997-10309","article-title":"The Pharmacoepidemiologic Prescription Database of North Jutland \u2014 a valid tool in pharmacoepidemiological research","volume":"10","author":"Nielsen","year":"1997","journal-title":"Int J Risk Saf Med"},{"issue":"12","key":"10.1016\/j.bone.2013.08.013_bb0085","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.amjmed.2008.06.036","article-title":"Antihistamine therapy and bone mineral density: analysis in a population-based US sample","volume":"121","author":"Kinjo","year":"2008","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.bone.2013.08.013_bb0090","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.metabol.2012.09.011","article-title":"Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: a prospective matched controlled study","volume":"62","author":"Sharara","year":"2013","journal-title":"Metabolism"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213003281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213003281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T07:15:59Z","timestamp":1596352559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328213003281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S8756328213003281"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2013.08.013","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}